Filing Flows › MeiraGTx Holdings (MGTX) › Recalls, complaints & regulation
MeiraGTx Holdings (MGTX): clinical trials
MeiraGTx Holdings (MGTX) beyond its filings: 7 active clinical trials.
MeiraGTx Holdings' latest quarter
MeiraGTx Holdings, Q2 2026: revenue $321M (87× year over year), operating margin 76.0%, net earnings $161M, operating cash flow −$38.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does MeiraGTx Holdings have?
7 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.